Literature DB >> 18063470

Craniopharyngioma: surgical experience of 309 cases in China.

Xiang-En Shi1, Bin Wu, Tao Fan, Zhong-Qing Zhou, Yong-Li Zhang.   

Abstract

OBJECTIVE: The objective of the present study was to retrospectively review the surgical outcome of 309 craniopharyngioma cases treated by a single neurosurgeon in China. PATIENTS AND METHODS: A total of 309 cases of craniopharyngioma that were treated surgically from January 1996 to May 2006. Among them, 162 (52.4%) patients were male and 147 (47.6%) were female. There were 259 (83.8%) patients older than 15 years (mean 35.8 years) and 50 (16.2%) younger than 15 years (mean 8.8 years). The tumor size varied in diameter from 2.0 cm to 9.0 cm (mean 34.5 mm). Pterional approach was performed in 211 (68.3%) cases, trans-laminal terminal approach through frontobasal interhemispheric fissure in 55 (17.8%) cases, subfrontal approach in 20 (6.5%) cases, and transcallosum approach into the anterior third ventricle in 11 (3.6%) cases.
RESULTS: Total, subtotal, and partial removal of tumors were achieved in 276 (89.3%), 20 (6.5%), and 13 (4.2%) patients, respectively. The pituitary stalk was preserved in 186 (60.2%) cases, severed in 49 (15.9%) cases, and unidentified in 74 (23.9%) cases during surgery. There were 12 (3.9%) patients died within 1 month after surgery. A total of 204 (66%) patients were followed from 6 months to 8 years (mean 2.1 years). In the 167 patients with total tumor removal, 23 (13.7%) had tumor recurrence within an average of 1.8 years. While, in the 32 patients with subtotal or partial resection, 24 (75%) had recurrence within an average of 0.5 years. There were five deaths occurred during follow-up.
CONCLUSION: Pre-surgery neuroimaging evaluations have improved our knowledge of intricate anatomical relationship between craniopharyngioma and the structures of the hypothalamus, pituitary stalk, and optic apparatus, which make total tumor resection feasible with the preservation of these vital structures to ensure a lower recurrence rate with acceptable mortality. However, excessive long-term morbidity, mostly related to hypopituitarism, which leads to the poor quality of life for the craniopharyngioma patients, is still remained. Further effort should be invested to monitor and maintain the normal hormone levels, hence improve the quality of life for craniopharyngioma patients.

Entities:  

Mesh:

Year:  2007        PMID: 18063470     DOI: 10.1016/j.clineuro.2007.10.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  19 in total

1.  Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma.

Authors:  Marco Losa; Valentina Pieri; Michele Bailo; Filippo Gagliardi; Lina Raffaella Barzaghi; Lorenzo Gioia; Antonella Del Vecchio; Angelo Bolognesi; Pietro Mortini
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

2.  Craniopharyngioma: history.

Authors:  Garni Barkhoudarian; Edward R Laws
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

3.  Successful surgery of the hypothalamic region: Yes, we can!

Authors:  Michael Buchfelder
Journal:  Endocrine       Date:  2018-05-15       Impact factor: 3.633

4.  Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma.

Authors:  Hiromitsu Iwata; Koshi Tatewaki; Mitsuhiro Inoue; Naoki Yokota; Yoshimi Baba; Ryutaro Nomura; Yuta Shibamoto; Kengo Sato
Journal:  J Neurooncol       Date:  2011-08-23       Impact factor: 4.130

5.  Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.

Authors:  Yuelong Wang; Jiaojiao Deng; Gang Guo; Aiping Tong; Xirui Peng; Haifeng Chen; Jianguo Xu; Yi Liu; Chao You; Liangxue Zhou
Journal:  J Neurooncol       Date:  2016-09-17       Impact factor: 4.130

6.  Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma.

Authors:  Agnieszka Ondruch; Agnieszka Maryniak; Tomasz Kropiwnicki; Marcin Roszkowski; Paweł Daszkiewicz
Journal:  Childs Nerv Syst       Date:  2010-10-08       Impact factor: 1.475

7.  Craniopharyngiomas: Surgery and Radiotherapy.

Authors:  Sergey Gorelyshev; Alexander N Savateev; Nadezhda Mazerkina; Olga Medvedeva; Alexander N Konovalov
Journal:  Adv Tech Stand Neurosurg       Date:  2022

Review 8.  Surgery for craniopharyngioma.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer; Fuhua Lin; Andrea Kleindienst
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 9.  Craniopharyngioma adherence: a reappraisal of the evidence.

Authors:  Ruth Prieto; José María Pascual; Verena Hofecker; Eduard Winter; Inés Castro-Dufourny; Rodrigo Carrasco; Laura Barrios
Journal:  Neurosurg Rev       Date:  2018-07-24       Impact factor: 3.042

Review 10.  The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma.

Authors:  G Minniti; V Esposito; M Amichetti; R Maurizi Enrici
Journal:  Neurosurg Rev       Date:  2009-01-23       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.